Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy
Clinical trial NCT04447118 · COMPLETED
Trial details
- NCT number
- NCT04447118
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2023-06-02
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.